Log In
Print
BCIQ
Print
Print this Print this
 

AG-221

  Manage Alerts
Collapse Summary General Information
Company Agios Pharmaceuticals Inc.
DescriptionInhibitor of mutated isocitrate dehydrogenase 2 (IDH2)
Molecular Target Isocitrate dehydrogenase 2 (IDH2)
Mechanism of ActionIsocitrate dehydrogenase 2 (IDH2) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today